UC San Diego Moores Cancer Center is the only San Diego hospital to be featured in Becker’s Hospital Review list of “70 Hospitals and Health Systems with Great Oncology Programs.”
A major Mexican-American advanced network project led on the U.S. side by the California Institute for Telecommunications and Information Technology (Calit2) has been honored by the Corporation for Education Network Initiatives in California (CENIC) as a recipient of the 2012 Innovations in Networking Award for High-Performance Research Applications.
Brain stimulation surgery for patients with Parkinson’s disease; promoting liver health on a national level; leading one of the nation’s top ALS clinics; and designing a law that protects the rights of students with epilepsy: these are significant reasons why four UC San Diego School of Medicine doctors were honored during the 18th annual Combined Health Agencies Health Hero Awards breakfast on March 15 at The Prado in Balboa Park.
A study by researchers at the University of California, San Diego School of Medicine and The University of Minnesota indicates that a parent’s weight change is a key contributor to the success of a child’s weight loss in family-based treatment of childhood obesity.
Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure.
When you think of Botox injections, you probably think of getting rid of unwanted wrinkles around the eyes or forehead, but recently the US Food and Drug Administration (FDA) approved using the injections to help patients with neurological conditions who suffer from incontinence, or an overactive bladder.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
